Homeritz’s 1HFY16 revenue of RM83.17m (+17% yoy) was translated into Adj PATAMI of RM16.97m (+72% yoy). This came in slightly above our expectation, which accounted for 55.6% of HLIB full year estimates.
Dividends
None (2QFY15: none).
Highlights
The company registered higher revenue and core earnings of RM83.17m and RM8.83m respectively, thanks to the strong US Dollar against MYR and higher sales volume which advanced by 2% yoy and 3% qoq.
However, the company recorded weaker EBITDA and adj PATAMI by 9% and 8% qoq respectively, mainly due to the one off staff bonus cost incurred in the current quarter and lower average selling price.
Utilization rate during the quarter was slightly higher at 82% (vs. 79% in 2QFY15) and we were guided that full year utilization rate for FY16 could be sustained at 80%.
The company currently owns a vacant land of circa 84,507 sq ft. which is close to its 5 existing factories. Based on management’s gui dance, this new factory could boost the company’s total production capacity by 19% or 570 containers per year vs. current production capacity of 3,000 containers per year. However, we only impute additional 142 containers per year (circa 25% of 570 containers) into FY17 earnings forecast.
Risks
USD weakness against RM; high raw material prices; high labour costs; unexpected economic downturn; and production or operational risks.
Forecasts
We update our forecast for FY16-17 based on latest guidance from management (mainly on lower projected average selling price). Hence, our forecasted EPS for FY16-17 is lowered by 11% and 21% respectively.
Rating
BUY
Posi tives: 1) beneficiary of strong US$; (2) lower leather price which will boost its margin; (3) forecasted FY16 net cash per share of 20 sen; and (4) FY16 DY of 5.2%, based on 50% payout ratio.
Valuation
We maintain our BUY recommendation with a lower target price of RM1.01 (previously RM1.28) based on unchanged P/E multiple of 11x of CY17 EPS.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....